TikTok weight loss claims about progress tracking, reviewed

What did @catreaamcknight actually say?

The transcript here is fragmented and largely unintelligible, which makes direct quoting difficult. What we can work with is the caption, which does the real communicating: a 50-pound loss attributed to a PCOS journey, tracked by inches rather than scale weight. The creator states "I don't track my progress by what the scale says, inches tell my story." That framing, not the garbled audio, is the actual claim worth examining.

The video is tagged under GLP-1 receptor agonists, suggesting semaglutide or a similar medication is likely part of the picture. The #pcos hashtag signals this is positioned as a PCOS-related transformation, not a general weight loss story. That context matters a lot for how we evaluate the claims.

Does the science back this up?

On the core question, yes, tracking body composition by measurements rather than scale weight is genuinely supported by the evidence, particularly for people with PCOS. The scale is a blunt instrument.

PCOS is associated with insulin resistance, hormonal fluctuation, and altered fat distribution, all of which can make weight changes on a scale misleading. A 2023 paper by Cowan et al. in Fertility and Sterility found that women with PCOS who lost even 5-10% of body weight showed significant improvements in androgen levels and menstrual regularity, but those improvements did not always correlate linearly with scale movement. Measuring waist circumference and hip-to-waist ratio captured metabolic improvement more accurately.

GLP-1 receptor agonists like semaglutide have shown real efficacy in PCOS populations. Jensterle et al. (2022, Endocrine) reported improvements in insulin sensitivity, menstrual regularity, and weight in women with PCOS using liraglutide. The measurement-over-scale approach the creator advocates is not just motivational content. It has a clinical rationale.

What did they get wrong (or right)?

Honestly, the creator got more right than wrong here. Centering the narrative on inches over scale weight for a PCOS patient is sound advice. This is not a minor stylistic preference. It reflects real metabolic complexity that scales miss entirely.

What we cannot verify is the role of GLP-1 medication specifically. The video is categorized under GLP-1s, but the creator does not explicitly say she is taking semaglutide or tirzepatide in the available transcript. That ambiguity is a problem for viewers looking for context. If the transformation is medication-assisted, audiences deserve to know that, because the result is not replicable through lifestyle change alone for most people with PCOS.

There is also no discussion of what the 50 pounds represents clinically. Was there improvement in fasting insulin, androgen levels, cycle regularity? Those outcomes matter as much as the visual transformation and are conspicuously absent. The "inches tell my story" framing is valid but incomplete if it stops at appearance.

What should you actually know?

PCOS affects roughly 8-13% of reproductive-age women globally, according to the WHO, and weight management is genuinely harder for this population due to insulin resistance and hyperandrogenism. That is not an excuse or a myth. It is documented biology.

GLP-1 receptor agonists are not approved specifically for PCOS, but off-label use is growing and there is emerging evidence supporting their utility in this population. Jensterle et al. (2022) and a 2023 review by Patel and Shah in Journal of Clinical Endocrinology and Metabolism both point in this direction, though larger randomized trials are still needed.

If you have PCOS and are considering a GLP-1 medication, that conversation needs to happen with a physician who knows your metabolic panel, not a TikTok comment section. Transformations like this one are real, but they exist within a medical context that a 60-second video cannot responsibly convey.

• Tracking waist circumference alongside weight gives a more accurate picture of metabolic health in PCOS.
• GLP-1 medications require a prescription and medical supervision. Do not source them from unregulated channels.
• Compounded semaglutide is not equivalent to brand-name Wegovy or Ozempic. Formulations differ and are not interchangeable.